Huitai medical: net profit in the first half of the year increased by 186.24% year-on-year

CCRC In China: A Rosy Picture for a Silver Future, but Still a Greenhorn Venture

The model of elderly care service represented by the United States, the Continuing Care Retirement Community (CCRC), is gradually attracting attention in China.

Unpacking China | Key Chinese Firms to Watch This Week （02/08/2026-08/08/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Blokees’ Overseas Revenue Surges 228.5% as Building Toys Gain Global Traction

Chinese building-toy company Blokees (布鲁可) reported on Aug. 12 that its overseas revenue reached CNY 366 million in the first half of 2026, up 228.5% year on year, as the company expanded its distribution and licensed-IP product portfolio across the Americas and Southeast Asia.

Wantai BioPharm’s Nine-Valent HPV Vaccine Wins First Overseas Approval in Thailand

Wantai BioPharm (万泰生物) announced on Aug. 11 that the nine-valent HPV vaccine developed by its wholly owned subsidiary, Xiamen Innovax Biotech (万泰沧海), has received marketing authorization from Thailand’s Food and Drug Administration. The approval marks the vaccine’s first clearance outside China and an important step in Wantai BioPharm’s international expansion.

Apple Reportedly Tests CXMT DRAM for China-Bound iPhones and Macs

Apple is reportedly testing DRAM chips made by ChangXin Memory Technologies (长鑫存储, CXMT) for possible use in iPhones and Mac computers sold in China, as the company looks for additional memory suppliers amid a global supply squeeze.